COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,738 Articles (22,502 medRxiv, 8,236 bioRxiv)

Most recent first Previous |  Page 90: Articles 891-900  | Next

SARS-CoV-2 JN.1 reveals attenuated pathogenicity and airborne transmission
Liu, R., Jin, Q., Wang, W., Zhang, C., Zhang, H., Li, B., Yan, F., Xia, X., Li, J., Wang, X., Gao, Y.
10.1101/2024.11.07.622580 — Posted: 2024-11-08
Lineage-specific neutralising antibodies after SARS-CoV-2 mild disease. Immune boosting effect of vaccination
Davina-Nunez, C., Perez, S., Cabrera-Alvargonzalez, J. J., Gonzalez-Alonso, E., Silva-Bea, S., Rodriguez-Perez, M., Perez-Gonzalez, A., del Campo, V., Figueroa-Lamas, M. d. P., Rojas, A., Mendoza, J., Regueiro-Garcia, B. J.
10.1101/2024.11.08.622599 — Posted: 2024-11-08
Follicular Bcl6 reactivity is associated with a unique immune landscape and spatial transcriptome in COVID-19
Brenna, C., Mora, B. B., Ioannidou, K., Burgermeister, S., Bodelet, J., Siebmanns, M., Georgakis, S., Orfanakis, M., Sedille, N., Feinstein, M., Lomasney, J. W., Chen, O. Y., Pantaleo, G., Berezowska, S., De Leval, L., Gottardo, R., Petrovas, C.
10.1101/2024.11.07.622471 — Posted: 2024-11-08
Estimating behavioural relaxation induced by COVID-19 vaccines in the first months of their rollout
Li, Y., Gozzi, N., Perra, N.
10.1101/2024.11.07.24316893 — Posted: 2024-11-07
SARS-CoV-2 infection enhancement by Amphotericin B: Implications for disease management
Nguyen, D., Laidlaw, S. M., Dong, X., Wand, M. E., Horton, A., Sutton, M., Tree, J., Milligan, R., Erdmann, M., Matthews, D. A., Davidson, A. D., Rahman, K. M., Hiscox, J. A., Carroll, M. W.
10.1101/2024.11.07.622419 — Posted: 2024-11-07
A Single Chimeric Spike Antigen Induces Pan-Sarbecovirus Immunity
Counoupas, C., Pino, P., Armitano, J., Johansen, M., Smith, L., Chan, E., Ashley, C., Estape, E., Troyon, J., Alca, S., Miemczyk, S., Hansbro, N., Scandurra, G., Britton, W. J., Courant, T., Dubois, P., Collin, N., Mohan, V. K., Hansbro, P. M., Wurm, M., Wurm, F., Steain, M., Triccas, J.
10.1101/2024.11.06.622391 — Posted: 2024-11-07
Impact of different synonymous codon substitution strategies on SARS-CoV-2 nucleocapsid protein expression in Escherichia coli
Bello, A. J., Omotuyi, A. O., Oladapo, O. B., Adekunle, A. A., UDECHIME, K. U., Akinwande, A. B., Odewale, A. F., Adamson, O. O., Eban, D. O., Folarin, O., Okpuzor, J., Minari, J. B.
10.1101/2024.11.06.622014 — Posted: 2024-11-07
Persistent Health and Cognitive Impairments Up to Four Years Post-COVID-19 in Young Students: The Impact of Virus Variants and Vaccination Timing
Latifi, A., Flegr, J.
10.1101/2024.11.06.24316832 — Posted: 2024-11-06
Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines
Chen, W., Tompkins, K. R., Windsor, I. W., Martinez, L. T., Ramos, M., Li, W., Shrivastava, S., Rajput, S., Chang, J. S., Sahasrabudhe, P., Fennell, K. F., McLellan, T. J., West, G. M., Dizon, K. P., Yam, A., Mitra, S., Saha, S., Sharaf, D., McKeen, A. P., Cadima, C. I., Muik, A., Swanson, W., Moreno, R. M., Daroca, P. M., Sahin, U., Anderson, A. S., Wu, H., Swanson, K. A., Modjarrad, K.
10.1101/2024.11.04.621927 — Posted: 2024-11-06
Nanoparticle-Supported, Rapid, Digital Quantification of Neutralizing Antibodies Against SARS-CoV-2 Variants
Mirjalili, S., Ikbal, M. A., Hou, C.-W., Kalatehmohammdi, M., Choi, Y., KELBAUSKAS, L., VanBlargan, L. A., Hogude, B. G., Murugan, V., Diamond, M. S., Wang, C.
10.1101/2024.11.05.622148 — Posted: 2024-11-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).